7-10 February 2023 Manchester
![]() |
![]() |
![]() |
![]() |
PO-5 | MUTATIONAL PROFILE OF SEVERE TUNISIAN PEOPLE WITH HEMOPHILIA A (PWH A) AND INHIBITORS. | Hejer Elmahmoudi | ![]() |
![]() |
|||
PO-8 | ARE ONE STAGE AND CHROMOGENIC FVIII:C ASSAYS SUITABLE FOR MEASURING ADYNOVI IN SPIKED PLASMA? | Susan Guy | ![]() |
![]() |
|||
PO-14 | EXPLORING RED BLOOD CELLS AS A NOVEL TOLEROGENIC APPROACH FOR FACTOR VIII INHIBITORS EMPLOYING IMMUNO-DOMINANT FVIII DERIVED PEPTIDES PRESENTED ON MHC CLASS II | Mariarosaria Miranda | ![]() |
![]() |
|||
PO-17 | ASSESSMENT OF LIVER FUNCTION IN CROATIAN PATIENTS WITH HAEMOPHILIA B | Josipa Pavic | ![]() |
![]() |
|||
PO-18 | EFANESOCTOCOG ALFA ACTIVITY ASSESSMENT WITH ONE-STAGE CLOTTING (OSA) AND CHROMOGENIC SUBSTRATE (CSA) FACTOR VIII ASSAYS | Sarah Meadows | ![]() |
![]() |
|||
PO-21 | DESIGN OF SECOND- AND THIRD-GENERATION FVIII-SPECIFIC CARS DIFFERENTLY IMPACTS PHENOTYPE STABILITY AND RESPONSES TOWARDS FVIII OF TRANSDUCED TREGS | Sarah Scatigna | ![]() |
![]() |
|||
PO-63 | RETROSPECTIVE STUDY OF THE EFFECTIVENESS AND SAFETY OF THE USE OF RIX-FP IN PATIENTS WITH HAEMOPHILIA B. EXPERIENCE OF FOUR CENTRES IN THE REGION OF CASTILLA Y LEÓN (C&L) | Natalia Carpizo | ![]() |
![]() |
|||
PO-77 | TEST-RETEST RELIABILITY ANALYSIS OF THE PATIENT REPORTED OUTCOMES BURDENS AND EXPERIENCES (PROBE) STUDY | Elizabeth Clearfield | ![]() |
![]() |
|||
PO-86 | HRQOL IMPACT AFTER INTRODUCING EMICIZUMAB IN SUB-SAHARAN AFRICA IN THE WFH HUMANITARIAN AID PROGRAM | Elizabeth Clearfield | ![]() |
![]() |
|||
PO-98 | AN OBSERVATIONAL STUDY TO EVALUATE THE IMPACT AND DISEASE BURDEN IN MODERATE AND SEVERE HEMOPHILIA FROM NURSING AND PATIENT PERSPECTIVE | Itziar Guerra | ![]() |
![]() |
|||
PO-99 | CORRELATION BETWEEN HEMOPHILIA EARLY ARTHROPATHY DETECTION WITH ULTRASOUND (HEAD-US) SCOREAND HEMOPHILIA JOINT HEALTH SCORE (HJHS) IN PATIENTS WITH HEMOPHILIA | Ons Ghali | ![]() |
![]() |
|||
PO-106 | EMICIZUMAB PROPHYLAXIS IN SEVERE HAEMOPHILIA A WITHOUT INHIBITORS: OUTCOME AND INDICATIONS. FROM THE UK HAEMOPHILIA CENTRE DOCTORS ORGANISATION | Charles Hay | ![]() |
![]() |
|||
PO-120 | TAWAM HOSPITAL, AL AIN, UAE EXPERIENCE WITH SWITCHING FROM STANDARD HALF-LIFE RECOMBINANT COAGULATION FACTOR IX TO EXTEND HALF-LIFE RECOMBINANT COAGULATION FACTOR IX, FC FUSION PROTEIN IN PATIENTS WITH SEVERE HEMOPHILIA B | Muhammad Faisal Khanani | ![]() |
![]() |
|||
PO-122 | PERIOPERATIVE MANAGEMENT WITH EFANESOCTOCOG ALFA IN PATIENTS WITH HEMOPHILIA A IN THE PHASE 3 XTEND-1 STUDY | Lois Roberts-Grant | ![]() |
![]() |
|||
PO-125 | BARRIERS TO HAEMOPHILIA CARRIERS IDENTIFICATION, SCREENING AND COUNSELLING AN INTERIM ANALYSIS OF THE PROCARRIERS1 STUDY | Evelien Krumb | ![]() |
![]() |
|||
PO-167 | THIRD INTERIM ANALYSIS OF THE PHASE IV HEM-POWR STUDY EVALUATING THE REAL-WORLD EFFECTIVENESS OF DAMOCTOCOG ALFA PEGOL IN PREVIOUSLY TREATED PATIENTS WITH HEMOPHILIA A | Bethany Lund-Yates | ![]() |
![]() |
|||
PO-170 | INSIGHTS INTO THE SPANISH MILD AND MODERATE HAEMOPHILIA A COHORT: REAL-WORLD EVIDENCE FROM THE CHESS II STUDY | Itziar Guerra | ![]() |
![]() |
|||
PO-175 | CLINICAL EXPERIENCE WITH EMICIZUMAB IN SUB-SAHARAN AFRICA: A WFH HUMANITARIAN AID PROGRAM REPORT | Elizabeth Clearfield | ![]() |
![]() |
|||
PO-176 | NEW PARADIGM IN THE TREATMENT OF HEMOPHILIA B: REAL-LIFE EXPERIENCE WITH RIX-FP | Cristina Sierra | ![]() |
![]() |
|||
PO-177 | IMPACT ON PAIN AND ACTIVITIES OF DAILY LIVING AFTER SWITCHING TO EMICIZUMAB: INSIGHTS FROM PROBE | Elizabeth Clearfield | ![]() |
![]() |
|||
PO-192 | BLEEDING CONTROL IMPROVES AFTER SWITCHING TO EMICIZUMAB: REAL WORLD EXPERIENCE FROM 251 CHILDREN IN THE PEDNET REGISTRY | Konrad van der Zwet | ![]() |
![]() |
|||
PO-194 | SUBCLINICAL SYNOVIAL PROLIFERATION IN PATIENTS WITH SEVERE HAEMOPHILIA A: ADVOCATING ULTRASOUND SCREENING | Flora van Leeuwen | ![]() |
![]() |
|||
PO-197 | DETERMINATION OF VITAMIN D IN PATIENTS WITH HEMOPHILIA AND DECREASED BONE MINERAL DENSITY | Laura Villarreal-Martinez | ![]() |
![]() |
|||
PO-198 | ISOKINETIC STRENGTH TESTING IN PATIENTS WITH HEMOPHILIA IN A HEMOPHILIA CLINIC IN MEXICO | Laura Villarreal-Martinez | ![]() |
![]() |
|||
PO-201 | PAIN MEMORIES IN HAEMOPHILIA PRELIMINARY RESULTS FROM A QUALITATIVE STUDY IN COLLABORATION WITH A PATIENT AND PUBLIC INVOLVEMENT GROUP | Anna Wells | ![]() |
![]() |
|||
PO-202 | TREATMENT OF BLEEDING EPISODES WITH EFANESOCTOCOG ALFA IN PATIENTS WITH SEVERE HAEMOPHILIA A IN THE PHASE 3 XTEND-1 STUDY | Ellie Hughes | ![]() |
![]() |
|||
PO-203 | PATIENT EXPERIENCE WITH EFANESOCTOCOG ALFA: RESULTS FROM THE XTEND-1 PHASE 3 CLINICAL TRIAL EXIT INTERVIEWS IN PATIENTS WITH SEVERE HAEMOPHILIA A | Nana Kragh | ![]() |
![]() |
|||
PO-214 | VEYVONDI IN A PAEDIATRIC POPULATION: A SINGLE-CENTRE EXPERIENCE | sahil bhagat | ![]() |
![]() |
|||
PO-217 | DIAGNOSIS AND MANAGEMENT OF HEAVY MENSTRUAL BLEEDING IN ADOLESCENTS IN PRIMARY CARE | Anne de Vaan | ![]() |
![]() |
|||
PO-222 | RECOMBINANT VON WILLEBRAND FACTOR TREATMENT OUTCOMES IN ADULTS WITH VON WILLEBRAND DISEASE IN THE UK: AN INTERIM ANALYSIS | Heena Howitt | ![]() |
![]() |
|||
PO-224 | STABLE FVIII EXPRESSION IN PATIENTS WITH VON WILLEBRAND DISEASE RECEIVING 1:1 RATIO VWF/FVIII CONCENTRATE | Geoffrey Kuppens | ![]() |
![]() |
|||
PO-233 | ISTH-BAT AS A DIAGNOSTIC SCREENING TOOL IN WOMEN AND GIRLS WITH HEAVY MENSTRUAL BLEEDING: A SYSTEMATIC REVIEW | Anne de Vaan | ![]() |
![]() |
|||
PO-245 | RECURRENT VENOUS THROMBOEMBOLIC DISEASE IN A PATIENT WITH SEVERE CONGENITAL FACTOR XIII DEFICIENCY. | Laura Bounaix | ![]() |
![]() |
|||
PO-249 | LONG-TERM EFFECTIVENESS OF PLASMINOGEN EYE DROPS IN PATIENTS WITH LIGNEOUS CONJUNCTIVITIS: THE ITALIAN EXPERIENCE | Cesare Dalla Porta | ![]() |
![]() |
|||
PO-260 | GRAY PLATELET SYNDROME WITH NBEAL2 MUTATION ASSOCIATED WITH DYSIMMUNITY | Birgit Frotscher | ![]() |
![]() |
|||
PO-267 | THROMBOCYTOPENIA DOES NOT ALWAYS MEAN ITP: A SINGLE CENTRE EXPERIENCE | Eman Hassan | ![]() |
![]() |
|||
PO-271 | IMPACT OF THERAPEUTIC PLASMA EXCHANGE ON INTACT PROTEIN S, APOLIPOPROTEIN CIII AND THE HEMOSTATIC POTENTIAL | Riitta Lassila | ![]() |
![]() |
|||
PO-281 | INHERITED AUTOSOMAL DOMINANT THROMBOCYTOPENIA: ONE FAMILY DESCRIPTION | Víctor Portela Piñeiro | ![]() |
![]() |
|||
PO-283 | MANAGEMENT OF BLEEDING DISORDERS OF UNKNOWN CAUSE (BDUC) IN A TERTIARY LONDON HOSPITAL | Sinthiya Punnialingam | ![]() |
![]() |
|||
PO-293 | CLINICAL APPLICATION OF MULTIGENE PANEL TESTING FOR DIAGNOSIS OF INHERITED COAGULATION DISORDERS | Christine Van Laer | ![]() |
![]() |
|||
PO-301 | LOCALISATION OF NATIONAL HAEMOPHILIA COMPETENCY FRAMEWORK FOR THE SHEFFIELD HAEMOPHILIA & THROMBOSIS CENTRE SERVICE | Cathy Harrison | ![]() |
![]() |
|||
PO-303 | IMPROVING PATIENT SAFETY WITH STAFF WELLBEING | Natasha Longsmith | ![]() |
![]() |
|||
PO-309 | PRESENTATION OF A QUESTIONNAIRE: WOMEN WITH BLEEDING DISORDERS | Malin Svennefalk | ![]() |
![]() |
|||
PO-310 | WHY AND HOW TO TALK ABOUT SEXUAL HEALTH | Nanda Uitslager | ![]() |
![]() |
|||
PO-324 | PSYCHOLOGICAL EXPERIENCES OF MOTHERS WITH SEVERE HAEMOPHILIAC CHILDREN IN IRANIAN CULTURE: A PHENOMENOLOGICAL STUDY | Reza Farahani | ![]() |
![]() |
|||
PO-325 | TEAM HAEM GOES GREEN - A PILOT PROJECT | Claire Forde | ![]() |
![]() |
|||
PO-328 | Development and useability testing of patient, caregiver and clinician tools to support shared decision making in haemophilia | Shade Olatunde | ![]() |
![]() |
|||
PO-332 | PERCEPTIONS OF A CAREER IN HAEMOSTASIS & THROMBOSIS - AN INTERNATIONAL PERSPECTIVE | Sinthiya Punnialingam | ![]() |
![]() |
|||
PO-333 | 360 VIRTUAL REALITY INCREASES TREATMENT ADHERENCE AND EMPOWERMENT IN PEOPLE WITH HEMOPHILIA: PRELIMINARY RESULTS. | Daniel-Anibal Garcia | ![]() |
![]() |
|||
PO-335 | IMPACT ON AND COMMUNICATION ABOUT SEXUAL FUNCTIONING IN MEN WITH HAEMOPHILIA IN THE NETHERLANDS (HIN-6). | Tessa van Gastel | ![]() |
![]() |
|||
PO-336 | WOMEN WITH BLEEDING DISORDERS AND THEIR EXPERIENCES IN DAILY LIFE FUNCTIONING IN THE NETHERLANDS. A QUALITATIVE STUDY. | Tessa van Gastel | ![]() |
![]() |
|||
PO-337 | TRAUMA WORK WITHIN AN INHERITED BLEEDING DISORDERS SERVICE USING EMDR | Sarah Whitaker | ![]() |
![]() |
|||
PO-338 | EXAMINING TREATMENT PREFERENCES OF PEOPLE WITH HAEMOPHILIA A AND B IN THE UK: A DISCRETE CHOICE EXPERIMENT ENCOMPASSING GENE THERAPY | George Morgan | ![]() |
![]() |
7-10 February 2023 Manchester
![]() |
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. ![]() To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. ![]() |
![]() |
||
![]() |
|